|
MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report) |
|
|
|
Titel: |
MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report) |
Auteur: |
Tateishi, Kazunari Mizugaki, Hidenori Ikezawa, Yasuyuki Morita, Ryo Yokoo, Keiki Sumi, Toshiyuki Kikuchi, Hajime Kitamura, Yasuo Nakamura, Atsushi Kobayashi, Maki Aso, Mari Kimura, Nozomu Yoshiike, Fumiaki Furuta, Megumi Tanaka, Hisashi Sekikawa, Motoki Hashiya, Tsutomu Fujita, Yuka Oizumi, Satoshi |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 34 () nr. S3 pagina's S1394 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|